Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FBXL9P encodes a pseudogene from the F-box protein family, which normally participate in the SCF (SKP1-cullin-F-box) ubiquitin ligase complex involved in protein degradation and cell signaling[2][5][8][9]. However, as a pseudogene, FBXL9P does not encode a functional protein and does not contribute to recognized biological functions, disease roles, or therapeutic strategies[4][8][2][3]. It is cataloged as part of the F-box and leucine rich repeat protein gene group but is not active[6][9]. The locus is found on human chromosome 16[6][1][8]. There is no evidence it acts as a receptor, enzyme, transporter, or any therapeutic target, and no drugs or biomarkers are associated with FBXL9P[2][4][8]. This entry is best interpreted as a non-target pseudogene and should not be confused with active members of the F-box protein family such as FBXL9 (the protein-coding gene).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on F-box and leucine rich repeat protein, pseudogene (FBXL9P).